A neurotrophic model for stress-related mood disorders

Biological Psychiatry
Ronald S Duman, Lisa M Monteggia

Abstract

There is a growing body of evidence demonstrating that stress decreases the expression of brain-derived neurotrophic factor (BDNF) in limbic structures that control mood and that antidepressant treatment reverses or blocks the effects of stress. Decreased levels of BDNF, as well as other neurotrophic factors, could contribute to the atrophy of certain limbic structures, including the hippocampus and prefrontal cortex that has been observed in depressed subjects. Conversely, the neurotrophic actions of antidepressants could reverse neuronal atrophy and cell loss and thereby contribute to the therapeutic actions of these treatments. This review provides a critical examination of the neurotrophic hypothesis of depression that has evolved from this work, including analysis of preclinical cellular (adult neurogenesis) and behavioral models of depression and antidepressant actions, as well as clinical neuroimaging and postmortem studies. Although there are some limitations, the results of these studies are consistent with the hypothesis that decreased expression of BDNF and possibly other growth factors contributes to depression and that upregulation of BDNF plays a role in the actions of antidepressant treatment.

References

Nov 1, 1979·Neuropharmacology·A D ShermanF A Henn
Jan 1, 1986·Psychopharmacology·B ThierryR D Porsolt
Jan 1, 1988·Psychopharmacology·S R BodnoffM J Meaney
Aug 9, 1996·Science·R M Sapolsky
Jan 1, 1997·Pharmacology, Biochemistry, and Behavior·J A SiuciakR M Lindsay
Jul 1, 1997·Archives of General Psychiatry·R S DumanE J Nestler
Oct 28, 1998·Proceedings of the National Academy of Sciences of the United States of America·D OngürJ L Price
Apr 15, 1999·Annual Review of Neuroscience·B S McEwen
May 20, 1999·Biological Psychiatry·G RajkowskaC A Stockmeier
Dec 11, 1999·Psychopharmacology·A Dalvi, I Lucki
Feb 26, 2000·Science·F H Gage
Sep 7, 2000·The Journal of Comparative Neurology·T D PalmerF H Gage
Nov 7, 2000·Biological Psychiatry·E GouldN Hastings
Nov 7, 2000·Biological Psychiatry·B S McEwen
Oct 25, 2001·Proceedings of the National Academy of Sciences of the United States of America·R M Sapolsky
Mar 7, 2002·Proceedings of the National Academy of Sciences of the United States of America·Per SvenningssonPaul Greengard
Apr 12, 2002·Brain Research. Developmental Brain Research·Michelle F AndersonPeter S Eriksson
May 1, 2002·Psychopharmacology·Andrew HolmesJacqueline N Crawley
May 15, 2002·Trends in Pharmacological Sciences·John F CryanIrwin Lucki
Jan 1, 1992·The European Journal of Neuroscience·Gisela Barbany, Håkan Persson
May 3, 2003·Neuropharmacology·A L CoppellT S C Zetterström
Jun 5, 2003·Nature Medicine·Napoleone FerraraJennifer LeCouter
Jun 6, 2003·The European Journal of Neuroscience·Jason BrownH Georg Kuhn
Jul 3, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jessica E Malberg, Ronald S Duman

❮ Previous
Next ❯

Citations

Feb 4, 2010·Archives of General Psychiatry·Ricardo E JorgeRobert G Robinson
Nov 26, 2010·Psychopharmacology·Gregory V Carr, Irwin Lucki
Jan 13, 2011·Psychopharmacology·Nicole R NugentLawrence H Price
Feb 11, 2011·Psychopharmacology·Montserrat Serra-MillàsCristóbal Gastó
May 19, 2011·Psychopharmacology·Lorenzo Di Cesare MannelliCarla Ghelardini
Jun 28, 2011·Psychopharmacology·Mariangela Martini, Olga Valverde
Aug 24, 2011·Psychopharmacology·Chisato WakabayashiHiroshi Kunugi
Sep 29, 2011·Psychopharmacology·Kamilla W MiskowiakLars V Kessing
Nov 16, 2011·Psychopharmacology·Maha M ElBatshD A Kendall
Apr 3, 2007·European Archives of Psychiatry and Clinical Neuroscience·Friederike Klempin, Gerd Kempermann
Apr 3, 2007·European Archives of Psychiatry and Clinical Neuroscience·Barbara VollmayrFritz A Henn
Mar 23, 2010·European Archives of Psychiatry and Clinical Neuroscience·Cagdas EkerAli Saffet Gonul
Feb 4, 2011·European Archives of Psychiatry and Clinical Neuroscience·Alessandra MinelliLuisella Bocchio-Chiavetto
Mar 26, 2013·Cell and Tissue Research·Olivia F O'Leary, John F Cryan
May 28, 2013·Cell and Tissue Research·Raffaella MolteniMarco A Riva
Apr 3, 2007·Journal of Neural Transmission·S AnttilaT Lehtimäki
Sep 4, 2008·Journal of Neural Transmission·Magdalena Sowa-KućmaGabriel Nowak
Apr 8, 2009·Journal of Neural Transmission·Joseph P HustonBianca Topic
Aug 6, 2010·Journal of Neural Transmission·Jucélia J FortunatoJoão Quevedo
Oct 15, 2011·Archives of Women's Mental Health·Erika ComascoAlkistis Skalkidou
Apr 1, 2008·Journal of Biological Physics·Victoria B Gradin, Andrés Pomi
Oct 22, 2010·Current Psychiatry Reports·Andrew F LeuchterBarry D Lebowitz
Feb 27, 2008·Neuromolecular Medicine·Benjamin N Greenwood, Monika Fleshner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.